Cargando…

Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome

BACKGROUND: Several studies point to a correlation between obesity and the severity of depressive and anxiety symptoms in children and adults, but there are still some controversial points about this association. The aim of this study is to investigate the relationship between body composition and t...

Descripción completa

Detalles Bibliográficos
Autores principales: Guedes, Erika P, Madeira, Eduardo, Mafort, Thiago T, Madeira, Miguel, Moreira, Rodrigo O, Mendonça, Laura MC, Godoy-Matos, Amélio F, Lopes, Agnaldo J, Farias, Maria Lucia F
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913787/
https://www.ncbi.nlm.nih.gov/pubmed/24364839
http://dx.doi.org/10.1186/1758-5996-5-82
_version_ 1782302288724885504
author Guedes, Erika P
Madeira, Eduardo
Mafort, Thiago T
Madeira, Miguel
Moreira, Rodrigo O
Mendonça, Laura MC
Godoy-Matos, Amélio F
Lopes, Agnaldo J
Farias, Maria Lucia F
author_facet Guedes, Erika P
Madeira, Eduardo
Mafort, Thiago T
Madeira, Miguel
Moreira, Rodrigo O
Mendonça, Laura MC
Godoy-Matos, Amélio F
Lopes, Agnaldo J
Farias, Maria Lucia F
author_sort Guedes, Erika P
collection PubMed
description BACKGROUND: Several studies point to a correlation between obesity and the severity of depressive and anxiety symptoms in children and adults, but there are still some controversial points about this association. The aim of this study is to investigate the relationship between body composition and the severity of anxiety/depressive symptoms in overweight and obese individuals with Metabolic Syndrome (MS). METHODS: Fifty patients, 18–50 years old, overweight or obese and with the diagnosis of MS based on the International Diabetes Federation (IDF) criteria were selected for this study. Body composition was evaluated using Dual Energy X-ray Absorptiometry (DXA). Depressive symptoms were evaluated using the Hospital Anxiety and Depression Scale (HADS-Depression) and the Beck Depression Inventory (BDI). Anxiety symptoms were evaluated using HADS-Anxiety. RESULTS: No correlation was found between depressive symptoms (HADS-Depression or BDI) and Body Mass Index (BMI) (r = 0.01; p = 0.94 and r = −0.12, p = 0.38; respectively), Waist Circumference (WC) (r = −0.06, p = 0.67 and r = −0.22, p = 0.12; respectively), and Waist-to-Hip Ratio (WHR) (r = −0.12, p = 0.40 and r = −0.17, p = 0.23; respectively). Additionally, no correlation was found among anxiety symptoms (HADS-Anxiety) and BMI (r = −0.15, p = 0.27), and WHR (r = −0.17, p = 0.24). In contrast, a significant correlation was found between percentage of total fat (DXA) and HADS-Depression (r = 0.34, p = 0.019) and HADS-Anxiety (r = 0.30, p = 0.039). Additionally, an inverse and strong correlation was found between lean mass (in grams) and HADS-Depression (r = −0.42, p = 0.004), HADS anxiety (r = −0.57, p < 0.0001), and BDI (r = −0.44, p = 0.026). CONCLUSIONS: In individuals with MS, the percentage of body fat, and not central fat, BMI, WC, or WHR, was associated with an increased severity of anxiety and depressive symptoms. In contrast, total lean mass was strongly associated with fewer anxiety/depressive symptoms, suggesting that body composition might be related to psychiatric comorbidity in overweight individuals with MS.
format Online
Article
Text
id pubmed-3913787
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-39137872014-02-06 Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome Guedes, Erika P Madeira, Eduardo Mafort, Thiago T Madeira, Miguel Moreira, Rodrigo O Mendonça, Laura MC Godoy-Matos, Amélio F Lopes, Agnaldo J Farias, Maria Lucia F Diabetol Metab Syndr Research BACKGROUND: Several studies point to a correlation between obesity and the severity of depressive and anxiety symptoms in children and adults, but there are still some controversial points about this association. The aim of this study is to investigate the relationship between body composition and the severity of anxiety/depressive symptoms in overweight and obese individuals with Metabolic Syndrome (MS). METHODS: Fifty patients, 18–50 years old, overweight or obese and with the diagnosis of MS based on the International Diabetes Federation (IDF) criteria were selected for this study. Body composition was evaluated using Dual Energy X-ray Absorptiometry (DXA). Depressive symptoms were evaluated using the Hospital Anxiety and Depression Scale (HADS-Depression) and the Beck Depression Inventory (BDI). Anxiety symptoms were evaluated using HADS-Anxiety. RESULTS: No correlation was found between depressive symptoms (HADS-Depression or BDI) and Body Mass Index (BMI) (r = 0.01; p = 0.94 and r = −0.12, p = 0.38; respectively), Waist Circumference (WC) (r = −0.06, p = 0.67 and r = −0.22, p = 0.12; respectively), and Waist-to-Hip Ratio (WHR) (r = −0.12, p = 0.40 and r = −0.17, p = 0.23; respectively). Additionally, no correlation was found among anxiety symptoms (HADS-Anxiety) and BMI (r = −0.15, p = 0.27), and WHR (r = −0.17, p = 0.24). In contrast, a significant correlation was found between percentage of total fat (DXA) and HADS-Depression (r = 0.34, p = 0.019) and HADS-Anxiety (r = 0.30, p = 0.039). Additionally, an inverse and strong correlation was found between lean mass (in grams) and HADS-Depression (r = −0.42, p = 0.004), HADS anxiety (r = −0.57, p < 0.0001), and BDI (r = −0.44, p = 0.026). CONCLUSIONS: In individuals with MS, the percentage of body fat, and not central fat, BMI, WC, or WHR, was associated with an increased severity of anxiety and depressive symptoms. In contrast, total lean mass was strongly associated with fewer anxiety/depressive symptoms, suggesting that body composition might be related to psychiatric comorbidity in overweight individuals with MS. BioMed Central 2013-12-23 /pmc/articles/PMC3913787/ /pubmed/24364839 http://dx.doi.org/10.1186/1758-5996-5-82 Text en Copyright © 2013 Guedes et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Guedes, Erika P
Madeira, Eduardo
Mafort, Thiago T
Madeira, Miguel
Moreira, Rodrigo O
Mendonça, Laura MC
Godoy-Matos, Amélio F
Lopes, Agnaldo J
Farias, Maria Lucia F
Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome
title Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome
title_full Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome
title_fullStr Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome
title_full_unstemmed Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome
title_short Body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome
title_sort body composition and depressive/anxiety symptoms in overweight and obese individuals with metabolic syndrome
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913787/
https://www.ncbi.nlm.nih.gov/pubmed/24364839
http://dx.doi.org/10.1186/1758-5996-5-82
work_keys_str_mv AT guedeserikap bodycompositionanddepressiveanxietysymptomsinoverweightandobeseindividualswithmetabolicsyndrome
AT madeiraeduardo bodycompositionanddepressiveanxietysymptomsinoverweightandobeseindividualswithmetabolicsyndrome
AT mafortthiagot bodycompositionanddepressiveanxietysymptomsinoverweightandobeseindividualswithmetabolicsyndrome
AT madeiramiguel bodycompositionanddepressiveanxietysymptomsinoverweightandobeseindividualswithmetabolicsyndrome
AT moreirarodrigoo bodycompositionanddepressiveanxietysymptomsinoverweightandobeseindividualswithmetabolicsyndrome
AT mendoncalauramc bodycompositionanddepressiveanxietysymptomsinoverweightandobeseindividualswithmetabolicsyndrome
AT godoymatosameliof bodycompositionanddepressiveanxietysymptomsinoverweightandobeseindividualswithmetabolicsyndrome
AT lopesagnaldoj bodycompositionanddepressiveanxietysymptomsinoverweightandobeseindividualswithmetabolicsyndrome
AT fariasmarialuciaf bodycompositionanddepressiveanxietysymptomsinoverweightandobeseindividualswithmetabolicsyndrome